CURE3d
First Patient Dosed With Recombinant Bacillus Calmette-Guérin in Bladder Cancer
Following the Bacillus Calmette-Guérin shortage, the first patient with bladder cancer has been dosed with recombinant ...
ImmunityBio announces 1st dosing of rBCG in U.S. and 60 sites pending
ImmunityBio (IBRX) announced U.S. Urology Partners, one of the nation’s largest independent providers of urology and related specialty ...
ImmunityBio Announces First Dosing of Recombinant BCG (rBCG) in the U.S. and 60 Sites Are in the Process of Launching
ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced U.S. Urology Partners, one of the nation’s ...
Targeted Oncology4d
EAP Enhances Access to Cretostimogene Grenadenorepvec
An expanded access program evaluating cretostimogene grenadenorepvec was highlighted during the 25th Annual Meeting of the ...
The Financial Express4d
India’s pharma industry betting big on CDMO opportunity – All you need to know
India’s Contract Development and Manufacturing Organization (CDMO) market is witnessing a strong growth trajectory driven by ...
JD Supra5d
US Emerging as Top Global Medtech Destination
For years, medtech firms around the globe (and certainly European companies) introduced their products in Europe, which requires obtaining a CE ...
European Medical Journal5d
Treatment Advances in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
BLADDER cancer is classified as either non-muscle invasive bladder cancer (NMIBC) or muscle-invasive bladder cancer (MIBC) ...